Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole oral solution for Tourette syndrome in children and adolescents
CTR20180142Phase 3Completed
- Sponsor
- Sichuan Otsuka Pharmaceutical
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in Tourette syndrome (TS), sponsored by Sichuan Otsuka Pharmaceutical. Started Feb 2018; status: completed.
02
Drugs
aripiprazole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on CTR20180142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180142.